November 15, 2017 / 7:02 AM / in 4 days

BRIEF-Hofseth Biocare Q3 EBITDA loss narrows to NOK 6.3 mln

Nov 15 (Reuters) - HOFSETH BIOCARE ASA:

* Q3 OPERATING REVENUE NOK ‍27.9​ MILLION VERSUS NOK 3.6 MILLION YEAR AGO

* Q3 EBITDA LOSS NOK ‍6.3 ​ MILLION VERSUS LOSS NOK 41.2 MILLION YEAR AGO

* ‍PRODUCED 665 TONS OF FINISHED PRODUCTS DURING Q3 OF 2017, UP 10 PER CENT FROM LAST QUARTER​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below